1. A randomised, double-blind, dose-finding, phase II multicentre study of ODX in the treatment of patients with castration-resistant prostate cancer and skeletal metastases. (March 2023) Authors: Thellenberg-Karlsson, Camilla; Vjaters, Egils; Kase, Marju; Tammela, Teuvo; Ojamaa, Kristiina; Norming, Ulf; Nyman, Claes; Andersson, Sven-Olof; Hublarovs, Oleg; Marquez-Holmberg, Marcela; Castellanos, Enrique; Ullen, Anders; Holmberg, Anders; Nilsson, Sten Journal: European journal of cancer Issue: Volume 181(2023) Page Start: 198 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A template for writing radiotherapy protocols. (February 2015) Authors: Nilsson, Per; Ceberg, Crister; Kjellén, Elisabeth; Gagliardi, Giovanna; Blomgren, Klas; Nilsson, Sten; Johansson, Mikael; Glimelius, Bengt Journal: Acta oncologica Issue: Volume 54:Number 2(2015) Page Start: 275 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Chemotherapy following radium‐223 dichloride treatment in ALSYMPCA. Issue 10 (23rd March 2016) Authors: Sartor, Oliver; Hoskin, Peter; Coleman, Robert E.; Nilsson, Sten; Vogelzang, Nicholas J.; Petrenciuc, Oana; Staudacher, Karin; Thuresson, Marcus; Parker, Christopher Journal: Prostate Issue: Volume 76:Issue 10(2016) Page Start: 905 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Comorbidity as a predictor of overall survival in prostate cancer patients treated with external beam radiotherapy combined with HDR brachytherapy boosts. (2nd January 2017) Authors: Hjälm-Eriksson, Marie; Ullén, Anders; Johansson, Hemming; Levitt, Seymoure; Nilsson, Sten; Kälkner, Karl-Mikael Journal: Acta oncologica Issue: Volume 56:Number 1(2017) Page Start: 21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effect of radium-223 dichloride (Ra-223) on hospitalisation: An analysis from the phase 3 randomised Alpharadin in Symptomatic Prostate Cancer Patients (ALSYMPCA) trial. (January 2017) Authors: Parker, Christopher; Zhan, Lin; Cislo, Paul; Reuning-Scherer, Jonathan; Vogelzang, Nicholas J.; Nilsson, Sten; Sartor, Oliver; O'Sullivan, Joe M.; Coleman, Robert E. Journal: European journal of cancer Issue: Volume 71(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. High levels of health-related quality of life five years after curative treatment of prostate cancer with HDR-brachytherapy and external beam radiation. (3rd October 2022) Authors: Hjälm-Eriksson, Marie; Ullén, Anders; Nilsson, Sten; Johansson, Hemming; Nilsson, Josef; Castellanos, Enrique; Brandberg, Yvonne Journal: Acta oncologica Issue: Volume 61:Number 10(2022) Page Start: 1179 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. High rate of local control and cure at 10 years after treatment of prostate cancer with external beam radiotherapy and high-dose-rate brachytherapy: a single centre experience. (3rd October 2021) Authors: Hjälm-Eriksson, Marie; Nilsson, Sten; Brandberg, Yvonne; Johansson, Hemming; Lennernäs, Bo; Lundell, Göran; Castellanos, Enrique; Ullén, Anders Journal: Acta oncologica Issue: Volume 60:Number 10(2021) Page Start: 1301 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Higher sexual interest with androgen receptor inhibitor monotherapy than with castration plus an androgen receptor inhibitor in prostate cancer patients treated with curative radiotherapy, but otherwise small health-related quality of life differences: A randomised prospective 18-month follow-up study. (September 2016) Authors: Majumder, Khairul; Nilsson, Sten; Johansson, Hemming; Ullén, Anders; Lennernäs, Bo; Bergenmar, Mia; Brandberg, Yvonne Journal: European journal of cancer Issue: Volume 65(2016) Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Progression-free and overall survival in metastatic castration-resistant prostate cancer treated with abiraterone acetate can be predicted with serial C11-acetate PET/CT. Issue 31 (August 2016) Authors: Farnebo, Jacob; Wadelius, Agnes; Sandström, Per; Nilsson, Sten; Jacobsson, Hans; Blomqvist, Lennart; Ullén, Anders Other Names: Lucarelli. Giuseppe section editor. Journal: Medicine Issue: Volume 95:Issue 31(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Progression-free and overall survival in metastatic castration-resistant prostate cancer treated with abiraterone acetate can be predicted with serial C11-acetate PET/CT. Issue 31 (August 2016) Authors: Farnebo, Jacob; Wadelius, Agnes; Sandström, Per; Nilsson, Sten; Jacobsson, Hans; Blomqvist, Lennart; Ullén, Anders Editors: Lucarelli., Giuseppe Journal: Medicine Issue: Volume 95:Issue 31(2016) Page Start: e4308 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗